Product NDC: | 24477-515 |
Proprietary Name: | Cardene |
Non Proprietary Name: | nicardipine hydrochloride |
Active Ingredient(s): | 30 mg/1 & nbsp; nicardipine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24477-515 |
Labeler Name: | EKR Therapeutics |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020005 |
Marketing Category: | NDA |
Start Marketing Date: | 19920221 |
Package NDC: | 24477-515-01 |
Package Description: | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24477-515-01) |
NDC Code | 24477-515-01 |
Proprietary Name | Cardene |
Package Description | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24477-515-01) |
Product NDC | 24477-515 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | nicardipine hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19920221 |
Marketing Category Name | NDA |
Labeler Name | EKR Therapeutics |
Substance Name | NICARDIPINE HYDROCHLORIDE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |